Healthcare provider profile · identity verified

Igor Giterman, M.D.

Family Practice · STATEN ISLAND, NY · NPI 1396090411

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	774	241
Amlodipine Besylate	Amlodipine Besylate	364	109
Losartan Potassium	Losartan Potassium	360	106
Levothyroxine Sodium	Levothyroxine Sodium	313	87
Simvastatin	Simvastatin	297	85
Metoprolol Succinate	Metoprolol Succinate	280	91
Pantoprazole Sodium	Pantoprazole Sodium	278	103
Fluticasone Propionate	Fluticasone Propionate	217	90
Metformin Hcl	Metformin Hcl	203	61
Tamsulosin Hcl	Tamsulosin Hcl	191	63
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	169	52
Rosuvastatin Calcium	Rosuvastatin Calcium	168	56
Lisinopril	Lisinopril	164	52
Ozempic	Semaglutide	150	35
Metoprolol Tartrate	Metoprolol Tartrate	136	47
Escitalopram Oxalate	Escitalopram Oxalate	130	50
Omeprazole	Omeprazole	125	42
Gabapentin	Gabapentin	123	53
Eliquis	Apixaban	122	37
Furosemide	Furosemide	121	39
Clopidogrel	Clopidogrel Bisulfate	119	32
Montelukast Sodium	Montelukast Sodium	114	29
Hydrochlorothiazide	Hydrochlorothiazide	108	36
Zolpidem Tartrate	Zolpidem Tartrate	108	22
Albuterol Sulfate Hfa	Albuterol Sulfate	102	41
Ibandronate Sodium	Ibandronate Sodium	101	33
Metformin Hcl Er	Metformin Hcl	94	37
Alprazolam	Alprazolam	85	19
Glipizide Er	Glipizide	84	29
Synthroid	Levothyroxine Sodium	83	26
Fenofibrate	Fenofibrate Nanocrystallized	79	25
Quetiapine Fumarate	Quetiapine Fumarate	78	25
Atenolol	Atenolol	70	21
Breo Ellipta	Fluticasone/Vilanterol	68	20
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	68	20
Allopurinol	Allopurinol	66	23
Trazodone Hcl	Trazodone Hcl	66	22
Famotidine	Famotidine	65	26
Jardiance	Empagliflozin	65	27
Enalapril Maleate	Enalapril Maleate	62	17
Sertraline Hcl	Sertraline Hcl	61	21
Terazosin Hcl	Terazosin Hcl	57	18
Pravastatin Sodium	Pravastatin Sodium	56	18
Mounjaro	Tirzepatide	55	11
Finasteride	Finasteride	54	16
Duloxetine Hcl	Duloxetine Hcl	51	11
Glipizide	Glipizide	49	19
Januvia	Sitagliptin Phosphate	49	16
Glimepiride	Glimepiride	48	18
Prednisone	Prednisone	47	41
Triamcinolone Acetonide	Triamcinolone Acetonide	47	25
Donepezil Hcl	Donepezil Hcl	46	16
Amitriptyline Hcl	Amitriptyline Hcl	45	16
Carvedilol	Carvedilol	44	14
Ezetimibe	Ezetimibe	43	15
Nifedipine Er	Nifedipine	43	16
Naproxen	Naproxen	42	27
Valsartan	Valsartan	42	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	12
Pregabalin	Pregabalin	38	11
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	36	12
Azelastine Hcl	Azelastine Hcl	36	15
Warfarin Sodium	Warfarin Sodium	36	suppressed
Alendronate Sodium	Alendronate Sodium	34	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	19
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Mirtazapine	Mirtazapine	33	12
Bupropion Xl	Bupropion Hcl	30	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Meloxicam	Meloxicam	30	14
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	16
Baclofen	Baclofen	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	23
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	11
Dutasteride	Dutasteride	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Methylprednisolone	Methylprednisolone	24	22
Topiramate	Topiramate	24	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	23	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Potassium Chloride	Potassium Chloride	23	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Calcitriol	Calcitriol	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Azithromycin	Azithromycin	17	17
Buspirone Hcl	Buspirone Hcl	17	suppressed
Colchicine	Colchicine	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	14	14
Klor-Con M20	Potassium Chloride	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Risperidone	Risperidone	14	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Xolair	Omalizumab	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	11
Fenofibrate	Fenofibrate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tiadylt Er	Diltiazem Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error